These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38443633)

  • 41. Subcutaneous Bioavailability of Taspoglutide at 3 Different Injection Sites in Healthy Overweight/Obese Subjects.
    Sturm-Pellanda C; Abt M; Sanwald-Ducray P; Schmitt C
    Clin Ther; 2015 Nov; 37(11):2439-48. PubMed ID: 26412802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions.
    Schneider A; Jost R; Jordi C; Lange J
    Expert Opin Drug Deliv; 2023 Jun; 20(6):815-830. PubMed ID: 37272119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subcutaneous injection of diclofenac for the treatment of pain following minor orthopedic surgery (DIRECT study): a randomized trial.
    Chiarello E; Bernasconi S; Gugliotta B; Giannini S
    Pain Pract; 2015 Jan; 15(1):31-9. PubMed ID: 24279691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue Resistance during Large-Volume Injections in Subcutaneous Tissue of Minipigs.
    Allmendinger A; Fischer S
    Pharm Res; 2020 Sep; 37(10):184. PubMed ID: 32888065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of manual pressure after subcutaneous injection on pain and comfort levels.
    Karabey T; Karagözoğlu Ş
    J Vasc Nurs; 2021 Dec; 39(4):134-139. PubMed ID: 34865724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
    McKay M; Compion G; Lytzen L
    Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immediate pain sensation is less with subcutaneous epoietin-beta compared to subcutaneous darbepoietin-alpha.
    Ter Wee PM; de Koter Y; van der Veer O; van Vliet MH
    Clin Nephrol; 2009 Sep; 72(3):177-80. PubMed ID: 19761721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Injection Technique and Pen Needle Design Affect Leakage From Skin After Subcutaneous Injections.
    Præstmark KA; Stallknecht B; Jensen ML; Sparre T; Madsen NB; Kildegaard J
    J Diabetes Sci Technol; 2016 Jul; 10(4):914-22. PubMed ID: 26798083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.
    Mohammady M; Janani L; Akbari Sari A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008077. PubMed ID: 29090459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.
    Mohammady M; Janani L; Akbari Sari A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD008077. PubMed ID: 28965359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic bioequivalence of enfuvirtide using a needle-free device versus standard needle administration.
    True AL; Chiu YY; Demasi RA; Stout R; Patel I
    Pharmacotherapy; 2006 Dec; 26(12):1679-86. PubMed ID: 17125431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain management in labour.
    Derry S; Straube S; Moore RA; Hancock H; Collins SL
    Cochrane Database Syst Rev; 2012 Jan; 1():CD009107. PubMed ID: 22258999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen.
    Kamimura T; Miyamoto T; Yokota N; Takashima S; Chong Y; Ito Y; Akashi K
    Eur J Haematol; 2013 Feb; 90(2):157-61. PubMed ID: 23240903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
    Landovitz RJ; Li S; Grinsztejn B; Dawood H; Liu AY; Magnus M; Hosseinipour MC; Panchia R; Cottle L; Chau G; Richardson P; Marzinke MA; Hendrix CW; Eshleman SH; Zhang Y; Tolley E; Sugarman J; Kofron R; Adeyeye A; Burns D; Rinehart AR; Margolis D; Spreen WR; Cohen MS; McCauley M; Eron JJ
    PLoS Med; 2018 Nov; 15(11):e1002690. PubMed ID: 30408115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial.
    Gligorov J; Curigliano G; Müller V; Knoop A; Jenkins V; Verma S; Osborne S; Lauer S; Machackova Z; Fallowfield L; Pivot X
    Breast; 2017 Aug; 34():89-95. PubMed ID: 28549309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large volume subcutaneous delivery using multi-orifice jet injection.
    McKeage JW; Tan AZH; Taberner AJ
    Int J Pharm; 2024 Jan; 649():123605. PubMed ID: 37981248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Injection pain and postinjection pain of the palatal-anterior superior alveolar injection, administered with the Wand Plus system, comparing 2% lidocaine with 1:100,000 epinephrine to 3% mepivacaine.
    Nusstein J; Burns Y; Reader A; Beck M; Weaver J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):164-72. PubMed ID: 14970775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site.
    Usach I; Martinez R; Festini T; Peris JE
    Adv Ther; 2019 Nov; 36(11):2986-2996. PubMed ID: 31587143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective clinical and pathological examination of injection site reactions with the HIV-1 fusion inhibitor enfuvirtide.
    Myers SA; Selim AA; McDaniel MA; Hall R; Zhang Y; Bartlett JA; True AL
    Antivir Ther; 2006; 11(7):935-9. PubMed ID: 17302257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.